Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 110,968
  • Shares Outstanding, K 16,612
  • Annual Sales, $ 27,040 K
  • Annual Income, $ 4,120 K
  • 60-Month Beta 0.60
  • Price/Sales 4.11
  • Price/Cash Flow 23.49
  • Price/Book 2.35
Trade SRTS with:

Options Overview Details

View History
  • Implied Volatility 83.22% ( +8.81%)
  • Historical Volatility 216.04%
  • IV Percentile 37%
  • IV Rank 41.24%
  • IV High 135.54% on 05/03/22
  • IV Low 46.49% on 01/19/22
  • Put/Call Vol Ratio 4.00
  • Today's Volume 25
  • Volume Avg (30-Day) 424
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 7,368
  • Open Int (30-Day) 9,917

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.22
  • Number of Estimates 2
  • High Estimate 0.28
  • Low Estimate 0.15
  • Prior Year 0.32
  • Growth Rate Est. (year over year) -31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.07 +6.50%
on 11/29/22
8.10 -20.25%
on 11/15/22
+0.12 (+1.89%)
since 11/04/22
3-Month
6.07 +6.50%
on 11/29/22
15.17 -57.42%
on 09/19/22
-6.05 (-48.36%)
since 09/06/22
52-Week
5.84 +10.62%
on 12/28/21
15.25 -57.64%
on 08/12/22
-0.94 (-12.70%)
since 12/06/21

Most Recent Stories

More News
Down 46.9% in 4 Weeks, Here's Why Sensus Healthcare, Inc. (SRTS) Looks Ripe for a Turnaround

Sensus Healthcare, Inc. (SRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts...

SRTS : 6.46 (-3.29%)
Sensus Healthcare, Inc. (SRTS) Q3 Earnings Lag Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -8.33% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

SRTS : 6.46 (-3.29%)
RXST : 12.77 (-7.66%)
SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -40% and 0.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SPNE : 7.26 (-5.35%)
SRTS : 6.46 (-3.29%)
Recent Price Trend in Sensus Healthcare, Inc. (SRTS) is Your Friend, Here's Why

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed...

SRTS : 6.46 (-3.29%)
Edwards Lifesciences (EW) Lags Q3 Earnings and Revenue Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of -1.61% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EW : 72.27 (-2.14%)
SRTS : 6.46 (-3.29%)
The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare

TransMedics, PROCEPT BioRobotics and Sensus Healthcare are part of the Zacks top Analyst Blog Highlights.

SRTS : 6.46 (-3.29%)
TMDX : 59.75 (-3.47%)
PRCT : 44.77 (-1.78%)
3 Resilient Medical Stocks to Watch as Rate Hikes Continue

Here we discuss three Medical-Instruments stocks - TMDX, PRCT & SRTS - that continued to grow in the first nine months of 2022 even though three Fed rate hikes dragged broader indices down.

SRTS : 6.46 (-3.29%)
TMDX : 59.75 (-3.47%)
PRCT : 44.77 (-1.78%)
EDAP TMS S.A. (EDAP) Moves 7.3% Higher: Will This Strength Last?

EDAP TMS S.A. (EDAP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase...

EDAP : 10.92 (-0.82%)
SRTS : 6.46 (-3.29%)
Take Advantage of the Dip: 3 Top Stocks To Consider

Take advantage of the downturn in the market and consider buying these three top stocks.

$DOWI : 33,596.34 (-1.03%)
DIA : 336.46 (-1.05%)
$SPX : 3,941.26 (-1.44%)
SPY : 393.83 (-1.44%)
$IUXX : 11,549.69 (-2.01%)
QQQ : 281.68 (-2.07%)
SRTS : 6.46 (-3.29%)
INSW : 40.75 (-5.08%)
GLNG : 24.20 (-2.30%)
IHI : 51.85 (-1.31%)
Take Advantage of the Dip: 3 Top Stocks To Consider

The market has taken a significant downturn this week. Traders and investors can take advantage of this move by looking for stocks that are expected to thrive in the near-term.

$DOWI : 33,596.34 (-1.03%)
DIA : 336.46 (-1.05%)
$SPX : 3,941.26 (-1.44%)
SPY : 393.83 (-1.44%)
$IUXX : 11,549.69 (-2.01%)
QQQ : 281.68 (-2.07%)
SRTS : 6.46 (-3.29%)
INSW : 40.75 (-5.08%)
GLNG : 24.20 (-2.30%)
IHI : 51.85 (-1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare,...

See More

Key Turning Points

3rd Resistance Point 7.16
2nd Resistance Point 6.96
1st Resistance Point 6.71
Last Price 6.46
1st Support Level 6.26
2nd Support Level 6.05
3rd Support Level 5.80

See More

52-Week High 15.25
Fibonacci 61.8% 11.66
Fibonacci 50% 10.55
Fibonacci 38.2% 9.43
Last Price 6.46
52-Week Low 5.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar